Skip to main content
. 2024 Feb 6;39(3):289–298. doi: 10.1007/s10654-024-01104-w

Table 4.

Estimated difference in probability (percentage points) of childhood atopic medication purchases by birth order. Comparison of OLS models (M1–M4) and sibling fixed effects models (M5) with 95% confidence intervals. (Sibling-population N = 324,306)

Birth order (ref. 1st) Birth order (ref. 1st)
2nd 3rd 4th + 2nd 3rd 4th +
Antihistamines Eczema medication
M1a -5.1 (-5.5; -4.7) -10.7 (-11.3; -10.2) -18.7 (-19.3; -18.1) -2.4 (-2.8; -2.0) -5.3 (-5.9; -4.8) -9.3 (-9.8; -8.7)
M1b -4.6 (-5.0; -4.2) -6.9 (-7.5; -6.3) -11.7 (-12.4; -11.0) -2.0 (-2.4; -1.7) -3.1 (-3.6; -2.5) -5.3 (-6.0; -4.6)
M2 -4.4 (-4.8; -4.0) -6.6 (-7.2; -6.0) -10.4 (-11.1; -9.7) -1.9 (-2.3; -1.6) -2.9 (-3.4; -2.3) -4.7 (-5.4; -4.0)
M3 -4.2 (-4.6; -3.8) -6.4 (-6.9; -5.8) -9.7 (-10.4; -9.0) -1.7 (-2.1; -1.3) -2.6 (-3.1; -2.0) -4.0 (-4.7; -3.3)
M4 -4.2 (-4.6; -3.8) -6.4 (-6.9; -5.8) -9.5 (-10.2; -8.8) -1.7 (-2.1; -1.3) -2.6 (-3.2; -2.1) -4.1 (-4.8; -3.4)
M5 -4.9 (-5.5; -4.4) -7.8 (-8.8; -6.7) -10.5 (-12.2; -8.8) -1.6 (-2.1; -1.0) -2.0 (-3.0; -0.9) -2.4 (-4.1; -0.7)
Asthma medication Epinephrine
M1a -1.4 (-1.8; -1.1) -4.0 (-4.4; -3.6) -6.3 (-6.7; -5.8) -0.5 (-0.7; -0.4) -1.2 (-1.3; -1.0) -1.9 (-2.1; -1.8)
M1b -1.2 (-1.6; -0.9) -2.6 (-3.1; -2.2) -4.0 (-4.5; -3.4) -0.5 (-0.6; -0.4) -0.9 (-1.1; -0.7) -1.4 (-1.6; -1.2)
M2 -1.2 (-1.5; -0.9) -2.5 (-3.0; -2.0) -3.6 (-4.1; -3.0) -0.5 (-0.6; -0.3) -0.9 (-1.1; -0.7) -1.2 (-1.5; -1.0)
M3 -1.1 (-1.4; -0.7) -2.4 (-2.8; -1.9) -3.2 (-3.7; -2.6) -0.4 (-0.5; -0.2) -0.8 (-1.0; -0.6) -1.1 (-1.3; -0.8)
M4 -1.0 (-1.4; -0.7) -2.4 (-2.9; -1.9) -3.1 (-3.7; -2.5) -0.4 (-0.5; -0.2) -0.8 (-1.0; -0.6) -1.1 (-1.3; -0.8)
M5 -0.5 (-1.0; -0.1) -1.0 (-1.8; -0.2) -1.5 (-2.8; -0.2) -0.5 (-0.7; -0.3) -1.1 (-1.4; -0.7) -1.6 (-2.1; -1.0)

Abbreviations; ref. = reference category

M1a adjusted for: child’s sex, birth year, and immigrant background. M1b: M1a + number of siblings. M2: M1 + region and urbanicity of residence

M3: M2 + household income and parental education. M4: M3 + mode of delivery and parental atopic medication purchases. M5: M4 + sibling fixed effects